{"id":6263,"date":"2020-08-04T13:36:53","date_gmt":"2020-08-04T13:36:53","guid":{"rendered":"https:\/\/cdtrp.ca\/?p=6263"},"modified":"2020-08-31T19:29:55","modified_gmt":"2020-08-31T19:29:55","slug":"glyconet-webinar-series-season-2","status":"publish","type":"post","link":"https:\/\/cdtrp.ca\/en\/glyconet-webinar-series-season-2\/","title":{"rendered":"GlycoNet Webinar Series &#8211; Season 2"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"--awb-bg-size:cover;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy\"><div class=\"fusion-text fusion-text-1 fusion-no-medium-visibility\"><p>GlycoNet was happy to present the season 2 of their <a href=\"https:\/\/canadianglycomics.ca\/training\/webinar-series\/\">Webinar Series<\/a>.<\/p>\n<h5>Past webinars &#8211; Season 2<\/h5>\n<ul>\n<li><strong>August 5, 2020<\/strong> &#8211; <em>A workshop for scientific writers<\/em> &#8211; Kate Pratt and Jonathon Simmons<\/li>\n<li><strong>August 12, 2020<\/strong> &#8211; <em>Chemical tools for studying glucosidase activity in complex biological samples<\/em>, Dr. Chris Phenix &#8211; <em>An engineered in vitro enzymatic pathway for the anticancer anthracycline deoxysugars: TDP-L-acosamine and TDP-L-daunosamine<\/em>, F. Ifthiha Mohideen<\/li>\n<li><strong>August 19, 2020<\/strong> &#8211; <em>Workshop: Computations approaches for designing small molecule inhibitors<\/em> &#8211; Dr. Rebecca Davis<\/li>\n<li><strong>August 26, 2020<\/strong> &#8211; De novo <em>synthesis of nucleoside analogues for medicinal chemistry purposes<\/em>, Dr. Robert Britton &#8211;<em>Bioprospecting CAZymes from intestinal microbiomes for the tailored degradation of non-starch dietary polysaccharides<\/em>, Dr, Kristin Low<\/li>\n<\/ul>\n<h5 style=\"text-align: center;\"><a href=\"https:\/\/canadianglycomics.ca\/training\/webinar-series\/\">See the full list of webinars here.<\/a><\/h5>\n<\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"margin-left: auto;margin-right: auto;margin-top:30px;margin-bottom:30px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e0dede;border-top-width:2px;\"><\/div><\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-text fusion-text-2\"><h4>About GlycoNet<\/h4>\n<p>&#8220;Supported by the Government of Canada through the federal <a href=\"https:\/\/www.nce-rce.gc.ca\/index_eng.asp\">Networks of Centres of Excellence (NCE) Program<\/a>, GlycoNet is a pan-Canadian initiative bringing together researchers, industry and academic partners to develop solutions to unmet health needs through the study of glycomics.<\/p>\n<p>GlycoNet builds on our world-leading network of glycomics researchers and trainees, government laboratories and industry partners. The Network addresses key challenges in human and animal health. GlycoNet\u2019s research, in collaboration with our partners, leads to novel approaches for preventing and treating disease.&#8221;<\/p>\n<p><strong>Their Vision<\/strong><\/p>\n<ul>\n<li>To deliver solutions to important health issues and improve quality of life of Canadians through glycomics.<\/li>\n<\/ul>\n<p><strong>Their Mission<\/strong><\/p>\n<ul>\n<li>Ensure that the Network and Canada are internationally recognized as the leader in glycomics research.<\/li>\n<li>Deliver exceptional training in glycomics research and entrepreneurship<\/li>\n<li>Bridge the translation gap between research and industry<\/li>\n<li>Translate research advances into tangible benefits for Canada<\/li>\n<\/ul>\n<h5 style=\"text-align: left;\"><a href=\"https:\/\/canadianglycomics.ca\/\">Please visit GlycoNet website for more information<\/a>.<\/h5>\n<\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":6,"featured_media":6265,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,75],"tags":[],"class_list":["post-6263","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general","category-featured"],"_links":{"self":[{"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/posts\/6263"}],"collection":[{"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/comments?post=6263"}],"version-history":[{"count":9,"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/posts\/6263\/revisions"}],"predecessor-version":[{"id":6667,"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/posts\/6263\/revisions\/6667"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/media\/6265"}],"wp:attachment":[{"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/media?parent=6263"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/categories?post=6263"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cdtrp.ca\/en\/wp-json\/wp\/v2\/tags?post=6263"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}